Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Proof-of-concept Trial of Topical Delgocitinib in Patients With Facial Vitiligo

NCT07820098 is registered in ClinicalTrials.gov with Lone Skov as lead sponsor.

NCT NCT07820098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07820098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Proof-of-concept Trial of Topical Delgocitinib in Patients With Facial Vitiligo
Lead sponsor
Lone Skov
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 8, 2026
Completion date
January 31, 2028
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo